T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.

Blood Adv · 2023 · PMC10206437 · PMID 36649566

Europe PMC DOI

hedged sentence

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

not quite significantP = .088so close (0.05 < p ≤ 0.1)

Although not quite significant, there was also some evidence for an improvement in OS (HR, 0.65 [95% CI, 0.39-1.07]; P = .088).

also in 653 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.